Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076078558> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2076078558 endingPage "205" @default.
- W2076078558 startingPage "205" @default.
- W2076078558 abstract "To describe the prevalence and management of anemia in cancer patients.This cross-sectional, observational survey was conducted in Italy and Austria. Centers prespecified one day, during a 4-month enrollment window, to report specific data collected during normal clinical practice for patients with non-myeloid tumors attending for chemotherapy (±radiotherapy) treatment. The primary endpoint was the prevalence of anemia as determined using a prespecified algorithm: hemoglobin (Hb) ≤10 g/dL on/within 3 days prior to visit; ongoing anemia treatment; physician diagnosis of anemia, together with ≥1 anemia symptom.Between November 18, 2010 and March 18, 2011, data for 1412 patients were collected (Italy n = 1130; Austria n = 282). Most patients (n = 1136; 80%) had solid tumors; 809 (57%) had received ≤3 chemotherapy cycles. The prevalence of anemia was 32% (95% confidence interval: 29.4%-34.2%); 196 patients (14%) were deemed anemic based on Hb ≤10 g/dL, 131 (9%) on ongoing anemia treatment, and 121 (9%) on physician diagnosis/anemia symptom. Overall, 1153 patients (82%) had Hb data; mean (standard deviation [SD]) Hb levels were 11.7 (1.7) g/dL. In total, 456 patients (32%) had anemia symptoms: fatigue (n = 392; 28%), depression (n = 122; 9%), and dyspnea (n = 107; 8%) were most common. Fifty-one patients (4%) had had their current chemotherapy cycle delayed due to anemia. On visit day, or ≤28 days prior, 91 (6%), 188 (13%), and 81 patients (6%) had evidence of whole blood/red blood cell transfusion, erythropoiesis-stimulating agent use, or iron use, respectively.On the prespecified study day, one-third of patients with non-myeloid tumors undergoing chemotherapy were found to be anemic and 13% had evidence of erythropoiesis-stimulating agent use then or in the 28 days prior." @default.
- W2076078558 created "2016-06-24" @default.
- W2076078558 creator A5007037844 @default.
- W2076078558 creator A5029343970 @default.
- W2076078558 creator A5030048731 @default.
- W2076078558 creator A5031898133 @default.
- W2076078558 creator A5040658545 @default.
- W2076078558 creator A5046997933 @default.
- W2076078558 creator A5049017377 @default.
- W2076078558 creator A5056600574 @default.
- W2076078558 creator A5057001950 @default.
- W2076078558 creator A5071719493 @default.
- W2076078558 date "2013-08-01" @default.
- W2076078558 modified "2023-09-26" @default.
- W2076078558 title "Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy" @default.
- W2076078558 doi "https://doi.org/10.2147/cmar.s45236" @default.
- W2076078558 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3739422" @default.
- W2076078558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23946669" @default.
- W2076078558 hasPublicationYear "2013" @default.
- W2076078558 type Work @default.
- W2076078558 sameAs 2076078558 @default.
- W2076078558 citedByCount "4" @default.
- W2076078558 countsByYear W20760785582014 @default.
- W2076078558 countsByYear W20760785582016 @default.
- W2076078558 countsByYear W20760785582017 @default.
- W2076078558 countsByYear W20760785582023 @default.
- W2076078558 crossrefType "journal-article" @default.
- W2076078558 hasAuthorship W2076078558A5007037844 @default.
- W2076078558 hasAuthorship W2076078558A5029343970 @default.
- W2076078558 hasAuthorship W2076078558A5030048731 @default.
- W2076078558 hasAuthorship W2076078558A5031898133 @default.
- W2076078558 hasAuthorship W2076078558A5040658545 @default.
- W2076078558 hasAuthorship W2076078558A5046997933 @default.
- W2076078558 hasAuthorship W2076078558A5049017377 @default.
- W2076078558 hasAuthorship W2076078558A5056600574 @default.
- W2076078558 hasAuthorship W2076078558A5057001950 @default.
- W2076078558 hasAuthorship W2076078558A5071719493 @default.
- W2076078558 hasBestOaLocation W20760785581 @default.
- W2076078558 hasConcept C126322002 @default.
- W2076078558 hasConcept C187212893 @default.
- W2076078558 hasConcept C2776694085 @default.
- W2076078558 hasConcept C2778248108 @default.
- W2076078558 hasConcept C2778917026 @default.
- W2076078558 hasConcept C44249647 @default.
- W2076078558 hasConcept C71924100 @default.
- W2076078558 hasConcept C90924648 @default.
- W2076078558 hasConceptScore W2076078558C126322002 @default.
- W2076078558 hasConceptScore W2076078558C187212893 @default.
- W2076078558 hasConceptScore W2076078558C2776694085 @default.
- W2076078558 hasConceptScore W2076078558C2778248108 @default.
- W2076078558 hasConceptScore W2076078558C2778917026 @default.
- W2076078558 hasConceptScore W2076078558C44249647 @default.
- W2076078558 hasConceptScore W2076078558C71924100 @default.
- W2076078558 hasConceptScore W2076078558C90924648 @default.
- W2076078558 hasLocation W20760785581 @default.
- W2076078558 hasLocation W20760785582 @default.
- W2076078558 hasLocation W20760785583 @default.
- W2076078558 hasLocation W20760785584 @default.
- W2076078558 hasOpenAccess W2076078558 @default.
- W2076078558 hasPrimaryLocation W20760785581 @default.
- W2076078558 hasRelatedWork W1881618843 @default.
- W2076078558 hasRelatedWork W2060861099 @default.
- W2076078558 hasRelatedWork W2358410098 @default.
- W2076078558 hasRelatedWork W2364664635 @default.
- W2076078558 hasRelatedWork W247025421 @default.
- W2076078558 hasRelatedWork W2615428502 @default.
- W2076078558 hasRelatedWork W2993353655 @default.
- W2076078558 hasRelatedWork W3022098942 @default.
- W2076078558 hasRelatedWork W3031844403 @default.
- W2076078558 hasRelatedWork W4312554960 @default.
- W2076078558 isParatext "false" @default.
- W2076078558 isRetracted "false" @default.
- W2076078558 magId "2076078558" @default.
- W2076078558 workType "article" @default.